DEVELOPMENT AND VALIDATION OF THE URINARY INCONTINENCE KINESIOPHOBIA SEVERITY SCALE
Development of the Kinesiophobia Severity Scale in Urinary Incontinence: A Validity and Reliability Study
This study aims to develop and validate a novel Turkish-language self-report instrument, the Kinesiophobia Severity Scale in Urinary Incontinence (KSS-UI), to assess movement avoidance and fear of movement associated with concerns about urinary leakage in individuals with urinary incontinence. Following scale development, its validity and reliability will be evaluated through psychometric analyses in accordance with the Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN) recommendations.
調査の概要
状態
状態
条件
条件
詳細な説明
This methodological study aims to develop and evaluate the validity and reliability of the Kinesiophobia Severity Scale in Urinary Incontinence (KSS-UI), a novel Turkish-language self-report instrument designed to assess fear of movement and movement avoidance associated with concerns about urinary leakage.
The study will include individuals with urinary incontinence, including stress, urgency, and mixed urinary incontinence. Participants will be recruited exclusively from individuals reporting urinary incontinence among relatives of patients attending the Physical Therapy and Rehabilitation Center. Individuals who meet the eligibility criteria and voluntarily agree to participate will be enrolled in the study. Written informed consent will be obtained from all participants before data collection.
Initially, an item pool was developed through a comprehensive literature review, semi-structured interviews with 15-20 individuals with urinary incontinence, and recommendations from experts in relevant clinical disciplines. Following ethical approval, the items will undergo content validity assessment by a multidisciplinary panel of at least 10 experts. Item relevance, clarity, simplicity, and necessity will be evaluated using the Content Validity Ratio (CVR), Content Validity Index (CVI), and modified kappa statistics.
Subsequently, face validity and comprehensibility will be assessed through cognitive interviews with 8-12 individuals. Items will be revised based on participant feedback. Pilot testing will be conducted to examine item distributions, floor and ceiling effects, corrected item-total correlations, internal consistency, and item discrimination.
Following these preliminary evaluations, the revised scale will be administered to eligible participants during a single assessment session. Questionnaire completion is expected to take approximately 15-20 minutes.
Psychometric analyses will be performed to evaluate the validity and reliability of the scale. Based on the findings, the final scale will be established, and a scoring and interpretation guide will be developed.
The study is expected to provide a valid and reliable instrument for assessing urinary incontinence-related kinesiophobia and contribute to the evaluation of movement-related fear and avoidance behaviors in individuals with urinary incontinence.
研究の種類
研究の種類
入学 (推定)
入学
連絡先と場所
研究連絡先
研究連絡先
- 名前：Esra BAYRAMOĞLU DEMİRDÖĞEN
- 電話番号：05426961169
- メール：esra.bayramoglu@ahievran.edu.tr
研究連絡先のバックアップ
- 名前：Esra BAYRAMOĞLU DEMİRDÖĞEN
- 電話番号：5426961169
- メール：esra.bayramoglu@ahievran.edu.tr
研究場所
-
-
Kırşehir
-
Kırşehir、Kırşehir、トルコ（Türkiye）、40100
- 募集
- Kırşehir Ahi Evran Üniversitesi
-
コンタクト：
- Esra BAYRAMOĞLU DEMİRDÖĞEN
- メール：esra.bayramoglu@ahievran.edu.tr
-
-
参加基準
適格基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
The study population will consist of adults aged 18 years or older who report urinary incontinence, including stress, urgency, and mixed urinary incontinence. Participants will be recruited from among relatives of patients attending the Physical Therapy and Rehabilitation Center. Eligible individuals who report urinary leakage at least once per week during the past three months, are able to read and understand Turkish, and voluntarily agree to participate will be included in the study. Individuals with active lower urinary tract infections or conditions that prevent independent completion of the questionnaires will be excluded.
説明
Inclusion Criteria:
- Being 18 years of age or older
- Reporting symptoms of incontinence at least once a week for the past 3 months (ICIQ-SF score ≥ 1)
- Having the ability to read and comprehend Turkish
- Having been informed about the study and provided written informed consent
Exclusion Criteria:
- Having an active lower urinary tract infection
- Inability to complete the scales independently due to cognitive impairment, advanced dementia, or limited literacy
- Individuals who refuse to participate in the study or do not sign the informed consent form
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 観測モデル：CASE_ONLY
- 時間の展望：CROSS_SECTIONAL
グループ/コホートの数
コホートと介入
グループ/コホートグループ/コホート |
|---|
|
Incontinance
This group will consist of individuals with urinary incontinence, including stress, urgency, and mixed urinary incontinence, who are recruited from among relatives of patients attending the Physical Therapy and Rehabilitation Center. Eligible participants who voluntarily agree to participate will complete the newly developed Kinesiophobia Severity Scale in Urinary Incontinence (KSS-UI) to assess fear of movement and movement avoidance associated with concerns about urinary leakage. The scale will undergo psychometric evaluation to assess its validity and reliability. No therapeutic intervention will be administered as part of the study. |
この研究は何を測定していますか？
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Content Validity of the Kinesiophobia Severity Scale in Urinary Incontinence (KSS-UI)
時間枠：During the initial expert evaluation, before participant recruitment for the main validation study.
|
The content validity of the newly developed scale will be evaluated by a multidisciplinary panel of at least 10 experts. Item relevance, clarity, simplicity, and necessity will be assessed using the Content Validity Ratio (CVR), Item-level Content Validity Index (I-CVI), Scale-level Content Validity Index (S-CVI), and modified kappa statistics. |
During the initial expert evaluation, before participant recruitment for the main validation study.
|
二次結果の測定
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Internal Consistency of the KSS-UI
時間枠：Baseline (single assessment session; approximately 15-20 minutes).
|
The internal consistency of the KSS-UI will be evaluated using Cronbach's alpha coefficient and corrected item-total correlations. The contribution of individual items to scale reliability will also be examined. |
Baseline (single assessment session; approximately 15-20 minutes).
|
|
Item Discrimination and Item Performance of the KSS-UI
時間枠：Baseline (single assessment session; approximately 15-20 minutes).
|
Item performance will be evaluated by examining item distributions, floor and ceiling effects, and corrected item-total correlations. Item discrimination will be assessed by comparing item scores between the upper and lower 27% of participants based on total scale scores. |
Baseline (single assessment session; approximately 15-20 minutes).
|
協力者と研究者
捜査官
捜査官
- 主任研究者：Esra BAYRAMOĞLU DEMİRDÖĞEN、Kırşehir Eğitim ve Araştırma Hastanesi
研究記録日
主要日程の研究
研究開始 (実際)
研究開始
一次修了 (推定)
一次修了
研究の完了 (推定)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
その他の研究ID番号
- KAEU-EBAYRAMOGLUD-010
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
Individual participant data will not be shared to protect participants' privacy and confidentiality, given the sensitive nature of urinary incontinence-related health information. Study findings will be reported in aggregate form.
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。